Nine Continents Medical
→
Coloplast
Acquisition · Cash · COLO-B · announced Nov 3, 2020
Announced
Nov 3, 2020
Closed
Nov 3, 2020
Economics
Cash()
Pre-deal · pre-deal mark: 2020, year precision · rounding grid ±$100M · Coloplast press release — Nine Continents Medical acquisition, 2020
$145M upfront + contingent milestone payment
Target
Nine Continents Medical
Pelvic Health · Clinical / therapeutic
HQ Dayton, OH · Founded 2014
Implantable tibial nerve stimulator (ITNS) for overactive bladder — miniaturized, self-powered device placed under local anesthesia; no patient activation or recharging required
- Globe Newswire — Coloplast press release (Nov 3, 2020)
Acquirer
Coloplast (COLO-B)
Pelvic Health
HQ Humlebæk, Denmark
Why this buyer
Curated copy from the verified dataset — not an 8-K LLM summary
Implantable tibial nerve stimulator enters Coloplast into OAB 3rd-line therapy market — 80M+ people globally with OAB symptoms, ~3M candidates for device therapy
Evidence ladder
Secondary (press / IR)
Globe Newswire — Coloplast press release (Nov 3, 2020)
Limitations
- Single-source or weak corroboration — treat valuation and timing as directional.
- $145M upfront + contingent milestone payment
- Pre-deal valuation sourced from: Coloplast press release — Nine Continents Medical acquisition, 2020. Pre-deal market-cap and funding citations do not corroborate the acquisition.
Valuation peers · Pelvic Health
Same sector, same deal type, announced within ±3 years, disclosed value within 0.25×–4× of this transaction. Ranked by evidence class, then same acquirer, until you sort.
| Why included | ||||
|---|---|---|---|---|
| Cogentix Medical | Laborie Medical Technologies | Mar 12, 2018 | same evidence class |
Other verified deals by Coloplast
Acquirer program history not already listed as a valuation peer or adjacency row.
No further verified deals
Other verified transactions by Coloplast are already listed above, or none are in the dataset.
Patient empowerment context
Patient empowerment baseline (HLTH 2022)
No curated mapping — Nine Continents Medical (Pelvic Health). HLTH/Outcomes4Me 2022 baseline is Breast cancer care continuum (HLTH 2022). No curated mapping for this target in the verified crosswalk.
Research workspace (includes heuristic crosswalk) →Related verified workspaces
Lacuna is a curated public-source sample, not a census of women's-health M&A. Coverage varies by sector, geography, disclosure availability, and women's-health scope. Undisclosed transaction values are excluded from disclosed-value totals.
Curated verified dataset v11 · updated 2026-10-19 · 1 citations on this deal · Data compiled from public sources for educational visualization. Verify independently before any commercial use.